Cargando…
Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin
BACKGROUND: Kaposi’s sarcoma (KS) is a common HIV-associated malignancy frequently associated with poor outcomes. It is the most frequently diagnosed cancer in major cities of Mozambique. Antiretroviral therapy is the cornerstone of KS treatment, but many patients require cytotoxic chemotherapy. The...
Autores principales: | Coldiron, Matthew E., Gutierrez Zamudio, Ana Gabriela, Manuel, Rolanda, Luciano, Gilda, Rusch, Barbara, Ciglenecki, Iza, Telnov, Alex, Grais, Rebecca F., Trellu, Laurence Toutous, Molfino, Lucas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791748/ https://www.ncbi.nlm.nih.gov/pubmed/33413521 http://dx.doi.org/10.1186/s13027-020-00341-4 |
Ejemplares similares
-
HIV-associated Kaposi’s sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010–2015
por: Fardhdiani, Vini, et al.
Publicado: (2018) -
Authors’ response to “Evaluation of Treatments for HIV-Associated Kaposi Sarcoma in Africa”
por: Coldiron, Matthew E., et al.
Publicado: (2021) -
Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
por: Udhrain, Ashish, et al.
Publicado: (2007) -
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma
por: Cainelli, Francesca, et al.
Publicado: (2009) -
Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)